Form 4 for OFIX Orthofix Medical Inc.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001209191-23-002650 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-09 | 2023-01-05 | OFIX | Hannon Jason | Dir | A - Grant | $0.00 | +14.1K | 31.3K | +82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | A | A | 14,052 | $0.00 | 31,285 | D | — | — | (F1) Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023. (F2) Includes 29,336 deferred stock units. |